Yang et al. recently demonstrated that by downregulating OPN expression in breast cancer cell lines with siRNA, the sensitivity of breast cancer cells to doxorubicin was enhanced by increasing cell senescence. This evidence concerns the gene SPP1 and breast carcinoma.